CompletedNot Applicable

Evaluation of the Effect of HFMT in Promoting Donor-site Wound Healing

China100 participantsStarted 2022-03-01

Plain-language summary

Autologous hair transplantation involves follicle extraction, trimming, and implantation. Follicle trimming improves efficiency and postoperative appearance, resulting in the discarded tissue known as hair follicle-derived microtissue (HFMT). In a clinical case, HFMT homogenate was applied to the FUE donor area wound, resulting in reduced pain, relief from itching, and faster healing compared to conventional treatment. This study aims to compare the effects of HFMT on FUE donor area wound healing.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 18-60 years who underwent FUE autologous hair transplantation. * The patient's liver and kidney function were normal, and the serum protein level before surgery was normal. Exclusion Criteria: * Patients with a history of smoking. * Those suffering from diseases that affect wound healing, such as diabetes or hyperglycemia. * Those with abnormal blood sugar. * Abnormal cardiopulmonary function. * There are foci of infection in or near the surgical area. * Scar hyperplasia or scar constitution. * Those with a history of neuralgia. * The patient took immunosuppressants, cytostatics, and hormonal anticoagulants before surgery and antibiotics.

What they're measuring

Changes in the area of the wound at the donor site

Timeframe: post op days 3, 5, 7, 14 and post op weeks 4, 6, 8, 12, 16, 24

Trial details

NCT IDNCT05839158

SponsorNanfang Hospital, Southern Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-31

View on ClinicalTrials.gov More Wound Heal trials